MedPath

The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia

Phase 3
Completed
Conditions
Type 2 Diabetes
Hyperlipidemia
Registration Number
NCT01360567
Lead Sponsor
Taipei City Hospital
Brief Summary

The aim of the study is to examine whether the extract of green tea is effective on type 2 diabetes and hyperlipidemia.

Detailed Description

Percent change Homa insulin resistance, cholesterol and triglycerol.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
102
Inclusion Criteria
  • Age 20--69 years old
  • Type 2 diabetes for > one year
  • TG >= 150 mg/dl or LDL >= 100 mg/dl
Exclusion Criteria
  • GPT > 80 mg/dl
  • Creatinine > 1.8 mg/dl
  • Pregnancy
  • AMI
  • Stroke
  • Operational or any not suitable patients diagnosis physician in charge

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Percent change of HOMA insulin resistance and TG16 weeks
Secondary Outcome Measures
NameTimeMethod
Percent change of HbA1C and Cholesterol16 weeks

Trial Locations

Locations (2)

Chung-Hua Hsu

🇨🇳

Taipei, Taiwan

Taipei City Hospital

🇨🇳

Taipei, Taiwan

Chung-Hua Hsu
🇨🇳Taipei, Taiwan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.